Cargando…
A narrative review of hyperthermic intrathoracic chemotherapy for advanced lung cancer
The traditional treatment of stage IV lung cancer is predominantly supportive or palliative. No current standardized guidelines promote the use of hyperthermic intrathoracic chemotherapy (HITHOC) in the treatment of advanced lung cancer with pleural involvement. Several small studies have examined t...
Autores principales: | Song, Kimberly, Flores, Raja M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263853/ https://www.ncbi.nlm.nih.gov/pubmed/34350273 http://dx.doi.org/10.21037/atm-20-6514 |
Ejemplares similares
-
Present and future of hyperthermic intrathoracic chemotherapy (HITHOC) in thoracic surgical oncology
por: Migliore, Marcello
Publicado: (2021) -
Hyperthermic intrathoracic chemotherapy (HITHOC): narrative review of the current literature, recommendations and future studies
por: Markowiak, Till, et al.
Publicado: (2021) -
Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma
por: Migliore, Marcello, et al.
Publicado: (2021) -
Hypertermic Intrathoracic Chemotherapy (HITHOC) for thymoma: a narrative review on indications and results
por: Aprile, Vittorio, et al.
Publicado: (2021) -
Assessment of concentration and penetration depth of cisplatin in human lung tissue after decortication and hyperthermic exposure
por: Larisch, Christopher, et al.
Publicado: (2021)